These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 25744065)

  • 1. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
    Tutunea-Fatan E; Majumder M; Xin X; Lala PK
    Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL21/CCR7 up-regulate vascular endothelial growth factor-D expression via ERK pathway in human non-small cell lung cancer cells.
    Sun L; Zhang Q; Li Y; Tang N; Qiu X
    Int J Clin Exp Pathol; 2015; 8(12):15729-38. PubMed ID: 26884842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
    Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
    Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.
    Weitzenfeld P; Kossover O; Körner C; Meshel T; Wiemann S; Seliktar D; Legler DF; Ben-Baruch A
    J Leukoc Biol; 2016 Jun; 99(6):1009-25. PubMed ID: 26936935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
    Pan MR; Hou MF; Chang HC; Hung WC
    J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
    Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
    Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis.
    Pang MF; Georgoudaki AM; Lambut L; Johansson J; Tabor V; Hagikura K; Jin Y; Jansson M; Alexander JS; Nelson CM; Jakobsson L; Betsholtz C; Sund M; Karlsson MC; Fuxe J
    Oncogene; 2016 Feb; 35(6):748-60. PubMed ID: 25961925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemotactic interaction between CCL21 and its receptor, CCR7, facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
    Zhao B; Cui K; Wang CL; Wang AL; Zhang B; Zhou WY; Zhao WH; Li S
    J Hepatobiliary Pancreat Sci; 2011 Nov; 18(6):821-8. PubMed ID: 21594558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
    Lala PK; Nandi P; Majumder M
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic Metastasis of NSCLC Involves Chemotaxis Effects of Lymphatic Endothelial Cells through the CCR7-CCL21 Axis Modulated by TNF-α.
    Zhang S; Wang H; Xu Z; Bai Y; Xu L
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33158173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
    Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
    J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential implication of IL-24 in lymphangiogenesis of human breast cancer.
    Frewer NC; Ye L; Sun PH; Owen S; Ji K; Frewer KA; Hargest R; Jiang WG
    Int J Mol Med; 2013 May; 31(5):1097-104. PubMed ID: 23546515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.
    Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B
    Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.
    Hayasaka H; Yoshida J; Kuroda Y; Nishiguchi A; Matsusaki M; Kishimoto K; Nishimura H; Okada M; Shimomura Y; Kobayashi D; Shimazu Y; Taya Y; Akashi M; Miyasaka M
    Cancer Sci; 2022 Apr; 113(4):1338-1351. PubMed ID: 35133060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization.
    Tejchman A; Lamerant-Fayel N; Jacquinet JC; Bielawska-Pohl A; Mleczko-Sanecka K; Grillon C; Chouaib S; Ugorski M; Kieda C
    Oncotarget; 2017 May; 8(19):31876-31887. PubMed ID: 28416768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma.
    Li F; Zou Z; Suo N; Zhang Z; Wan F; Zhong G; Qu Y; Ntaka KS; Tian H
    Med Oncol; 2014 Sep; 31(9):180. PubMed ID: 25142946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.